Yulong Mi
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Jichao Qin (5 shared papers)Hui Zhao (4 shared papers)Hongzhi Hu (1 shared paper)Xingrui Li (1 shared paper)Jianping Gong (1 shared paper)Yiping Wu (1 shared paper)Chao Yan (1 shared paper)Deding Tao (4 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Cell Death and Disease (3 papers)Cancer Letters (1 paper)Gut Microbes (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Yulong Mi
11 papers receiving 312 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 140
- Oncology 82
- Molecular Biology 186
- Immunology and Allergy 8
- Biotechnology 12
Countries citing papers authored by Yulong Mi
This map shows the geographic impact of Yulong Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulong Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulong Mi more than expected).
Fields of papers citing papers by Yulong Mi
This network shows the impact of papers produced by Yulong Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulong Mi. The network helps show where Yulong Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yulong Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 175 | |
| 2 | 2022 | 48 | |
| 3 | 2020 | 31 | |
| 4 | 2023 | 19 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2025 | 0 | |
| 13 | 2023 | 0 | |
| 14 | 2025 | 0 |
About Yulong Mi
Yulong Mi is a scholar working on Oncology, Surgery, Molecular Biology, Cell Biology and Immunology, having authored 14 papers that have together received 314 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), RNA Research and Splicing (1 paper), Immune Cell Function and Interaction (1 paper), Epigenetics and DNA Methylation (1 paper), CAR-T cell therapy research (1 paper), Mycobacterium research and diagnosis (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Cancer Research (140 citations), Oncology (82 citations), Molecular Biology (186 citations), Immunology and Allergy (8 citations) and Biotechnology (12 citations). Yulong Mi has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Jichao Qin, Hui Zhao, Hongzhi Hu, Xingrui Li, Jianping Gong, Yiping Wu, Chao Yan, Deding Tao, Yibing Hu and Xiaolan Li. Their work appears in journals such as Frontiers in Oncology, Cell Death and Disease, Cancer Letters, Gut Microbes and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.